Physician

Ralph Cutler Quillin, MD

According to 2025 Medicare claims, Ralph Quillin, MD (NPI: 1720212269) practices unknown physician specialty in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY, LLC (NPI: 1801840434; TIN: 311405915) and primary practice location at 45219-2316. Quillin is affiliated with the Healthcare Solutions Network (ACO ID: A3283) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Quillin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 72 traditional Medicare patients, billed 321 HCPCS/CPT codes, and received $81,843 in Medicare payments. The top billing code was 47135 (Transplantation of donor liver). Part D data shows 673 prescription claims across 81 beneficiaries totaling $73,682 in drug costs, led by Valganciclovir Hcl (Valganciclovir Hcl). DME data shows 209 claims. Open Payments data shows 18 records totaling $47,860. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $5,899 and ending at $81,843. Concurrently, Part D prescription costs have risen steadily, from $2,725 to $73,682. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	15	31	$5,899
2017	68	128	$27,404
2018	93	271	$60,338
2019	138	463	$112,806
2020	136	416	$86,643
2021	130	389	$74,262
2022	107	304	$55,623
2023	75	465	$124,852
2024	72	321	$81,843

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	23	26	$2,725
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	14	$1,548
2019	28	47	$3,609
2020	43	151	$22,013
2021	37	99	$7,432
2022	43	143	$59,684
2023	64	321	$32,941
2024	81	673	$73,682

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	11	$65
2019	N/R	45	$1,316
2020	N/R	23	$8,388
2021	N/R	26	$11,958
2022	N/R	12	$139
2023	30	111	$1,901
2024	59	209	$4,096

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
47135	Transplantation of donor liver	17	17	$2,644
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	19	27	$105
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	17	18	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	17	20	$74
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	34	141	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Valganciclovir Hcl	Valganciclovir Hcl	27	1,094	$22,618
Eliquis	Apixaban	20	596	$11,257
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	670	$1,387
Pantoprazole Sodium	Pantoprazole Sodium	35	1,890	$415
Gabapentin	Gabapentin	21	769	$222

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	22	50	$2,101
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	23	56	$690
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	14	30	$546
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	28	$457
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	20	$266

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$47,860	Organ Recovery Systems, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ralph Cutler Quillin, MD?

Tedicare shows public-source Medicare data for Ralph Cutler Quillin, MD (NPI 1720212269), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ralph Cutler Quillin, MD have ACO affiliation data?

Ralph Cutler Quillin, MD is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Ralph Cutler Quillin, MD?

Ralph Cutler Quillin, MD is linked to UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY, LLC (billing NPI 1801840434) in the available physician profile data.

Does Ralph Cutler Quillin, MD have Open Payments data?

Ralph Cutler Quillin, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.